Health hazard evaluation report: HETA-80-242-1106, Sterling Organics, Rensselaer, New York.
Authors
Baker D; Fannick N; Hills B
Source
Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, HETA 80-242-1106, 1984 Jan; :1-8
The incidence of dermatitis due to p-nitrobenzyl-bromide (100118) (PNB) exposure was investigated on September 30, 1980 at Sterling Organics (SIC-0286), Rensselaer, New York. The evaluation was requested by the International Chemical Workers Union on behalf of about 15 PNB production workers. Work practices and processes were evaluated, and wipe samples collected from various work surfaces were analyzed for PNB, p-nitrobenzyl-amine (7409305) (PNA), and p- nitrobenzyl-alcohol (619738). Workers were examined for dermatitis and medical records were reviewed. The washing agents used for removal of PNB from the skin were compared to the 2 percent ammonia in water solution used at the facility. Only one sample contained a detectable amount of p-nitrobenzyl-alcohol. None of the samples contained detectable amounts of PNB or PNA. None of the workers had dermatitis at the time of the study, and no cases had been reported since the company began spraying potentially contaminated surfaces with the ammonia solution. The three alternate solutions were not as effective as the ammonia solution in removing PNB from the skin. The authors conclude that PNB is an intense primary irritant and sensitizer; however, current engineering controls and work practices appear to provide adequate protection.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.